Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Sarada Subramanian"'
Publikováno v:
Annals of Indian Academy of Neurology, Vol 19, Iss 2, Pp 205-210 (2016)
Background and Purpose: Definitive diagnosis of Creutzfeldt–Jakob disease (CJD) requires demonstration of infective prion protein (PrPSc) in brain tissues by immunohistochemistry or immunoblot, making antemortem diagnosis of CJD difficult. The Worl
Externí odkaz:
https://doaj.org/article/4cfd2fa5759b47fba26945185502f061
Autor:
Maya Mathew, Sarada Subramanian
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e86804 (2014)
Inhibition of Acetylcholinesterase (AChE) is still considered as the main therapeutic strategy against Alzheimer's disease (AD). Many plant derived phytochemicals have shown AChE inhibitory activity in addition to the currently approved drugs for AD.
Externí odkaz:
https://doaj.org/article/adf8037dc0a741b5a2ae0e36c38d8c9b
Autor:
Geethu, Krishna, Rashmi, Santhoshkumar, Palanimuthu Thangaraju, Sivakumar, Suvarna, Alladi, Anita, Mahadevan, Ajit B, Dahale, Faheem, Arshad, Sarada, Subramanian
Publikováno v:
Journal of Alzheimer's Disease. :1-11
Background: Alzheimer’s disease (AD) and frontotemporal dementia (FTD) are pathologically distinct neurodegenerative disorders with certain overlap in cognitive and behavioral symptoms. Both AD and FTD are characterized by synaptic loss and accumul
Publikováno v:
NeuroRegulation. 9:127-134
Autor:
Geethu Krishna, Mathew Varghese, Sarada Subramanian, Preeti Sinha, Palanimuthu T. Sivakumar, Ajit Bhalchandra Dahale
Publikováno v:
Asian journal of psychiatry. 58
Autor:
Mathew Varghese, Ajit Bhalchandra Dahale, Thomas Gregor Issac, Geethu Krishna, Anu Kn Unni, Preeti Sinha, Palanimuthu T. Sivakumar, Shiva Shanker Reddy Mukku, Sarada Subramanian, Lakshmi Prabha M
Publikováno v:
Asian journal of psychiatry. 53
Prolidase enzyme, which catalyzes the final step in collagen metabolism can influence the cognitive functions through changes in extracellular matrix (ECM) resulting in altered synaptic connectivity in Alzheimer's disease (AD). In this study, it was
Autor:
Sarada Subramanian, Palanimuthu T. Sivakumar, Mathew Varghese, Ajit Bhalchandra Dahale, Susheel Kumar J, Preeti Sinha, Geethu Krishna
Publikováno v:
Asian Journal of Psychiatry. 66:102914
Based on the reduction of amyloid β plaques, US FDA has recently approved Aducanumab as a disease modifying treatment for Alzheimer's disease (AD). With high pricing and the potential risks likely with this treatment, certainty of AD diagnosis becom
Autor:
Anu Kn, Ajit Bhalchandra Dahale, Shiva Shanker Reddy Mukku, Geethu Krishna, Mariamma Philip, Rashmi Santhosh Kumar, B K Chandrasekhar Sagar, Sarada Subramanian, Thomas Gregor Issac, Palanimuthu T. Sivakumar
Publikováno v:
Asian journal of psychiatry. 48
Publikováno v:
Biochemical and Biophysical Research Communications. 483:585-589
Alzheimer's disease (AD) is the leading cause of dementia, characterized by progressive loss of memory and other cognitive functions. The cognitive impairment in patients with AD is closely associated with loss of synapses and the formation of neurof
Publikováno v:
Annals of Indian Academy of Neurology
Annals of Indian Academy of Neurology, Vol 19, Iss 2, Pp 205-210 (2016)
Annals of Indian Academy of Neurology, Vol 19, Iss 2, Pp 205-210 (2016)
Background and Purpose: Definitive diagnosis of Creutzfeldt–Jakob disease (CJD) requires demonstration of infective prion protein (PrPSc) in brain tissues by immunohistochemistry or immunoblot, making antemortem diagnosis of CJD difficult. The Worl